Cargando…
The role of hydroxyurea to prevent silent stroke in sickle cell disease: Systematic review and meta-analysis
BACKGROUND: Chronic blood transfusions are standard of care for stroke prevention in sickle cell disease but is not cost effective and not without risks. Hydroxyurea has emerged as an option in the prevention of silent stroke in sickle cell disease. OBJECTIVE: To evaluate the role of hydroxyurea in...
Autores principales: | Hasson, Carla, Veling, Lisa, Rico, Juan, Mhaskar, Rahul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940152/ https://www.ncbi.nlm.nih.gov/pubmed/31860969 http://dx.doi.org/10.1097/MD.0000000000018225 |
Ejemplares similares
-
From Infancy to Adolescence: Fifteen Years of Continuous Treatment With Hydroxyurea in Sickle Cell Anemia
por: Hankins, Jane S., et al.
Publicado: (2014) -
Pilot study to estimate the safety and effectiveness of hydroxyurea and methotrexate recurrent langerhans cell histiocytosis (LCH-HU-pilot)
por: Sakamoto, Kenichi, et al.
Publicado: (2022) -
Nosocomial infections in sickle cell anemia patients: Prevention through multi-disciplinary approach: A review
por: Obeagu, Emmanuel Ifeanyi, et al.
Publicado: (2023) -
Understanding Sickle cell disease: Causes, symptoms, and treatment options
por: Elendu, Chukwuka, et al.
Publicado: (2023) -
Environmental Influences on Daily Emergency Admissions in Sickle-Cell Disease Patients
por: Mekontso Dessap, Armand, et al.
Publicado: (2014)